# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 135: Amendment of regulation 168 (use of non-prescription medicines in the course of a business)


In regulation 168, in paragraph (8)—
(a) in sub-paragraph (a), for “EEA State” substitute “approved country for import”; and
(b) for sub-paragraph (b) substitute—
“(b) imported from an approved country for import—
(i) it is manufactured or assembled in that country by a person who is the holder of an authorisation in that country in relation to its manufacture or assembly, and
(ii) it is imported by the holder of a wholesale dealer’s licence under Part 3 that includes the import of a medicinal product from such a country.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179185/regulation/135 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-135
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.